Overview

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this phase III study is to determine the efficacy of difluprednate in the treatment of inflammation following ocular surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Sirion Therapeutics, Inc.
Treatments:
Difluprednate
Fluprednisolone